Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Notes Payables (2016 - 2021)

Historic Notes Payables for Creative Medical Technology Holdings (CELZ) over the last 8 years, with Q3 2021 value amounting to $2.7 million.

  • Creative Medical Technology Holdings' Notes Payables rose 20197.26% to $2.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.7 million, marking a year-over-year increase of 20197.26%. This contributed to the annual value of $788701.0 for FY2020, which is 2575.3% down from last year.
  • Creative Medical Technology Holdings' Notes Payables amounted to $2.7 million in Q3 2021, which was up 20197.26% from $117267.0 recorded in Q2 2021.
  • Over the past 5 years, Creative Medical Technology Holdings' Notes Payables peaked at $2.7 million during Q3 2021, and registered a low of $100000.0 during Q1 2017.
  • Its 5-year average for Notes Payables is $688222.2, with a median of $682056.0 in 2018.
  • Per our database at Business Quant, Creative Medical Technology Holdings' Notes Payables skyrocketed by 34579.84% in 2019 and then tumbled by 8879.61% in 2021.
  • Over the past 5 years, Creative Medical Technology Holdings' Notes Payables (Quarter) stood at $251748.0 in 2017, then soared by 170.93% to $682056.0 in 2018, then skyrocketed by 55.74% to $1.1 million in 2019, then fell by 25.75% to $788701.0 in 2020, then skyrocketed by 247.84% to $2.7 million in 2021.
  • Its Notes Payables stands at $2.7 million for Q3 2021, versus $117267.0 for Q2 2021 and $327225.0 for Q1 2021.